Pressemappe: Kowa
Aktuelle Aussendungen (4 Treffer in 60 Monaten)
Kowa Announces First EU Marketing Authorisation for Pitavastatin Granted in the UK =
OTE0007 / 17.08.2010 / 16:34:33 / Channel: Wirtschaft / Aussender: Kowa
Pitavastatin Demonstrates Sustained Efficacy, Tolerability and LDL-C Target Attainment Over 52 Weeks =
OTE0014 / 28.04.2010 / 14:01:09 / Channel: Wirtschaft / Aussender: Kowa
Pitavastatin Demonstrates no Significant Drug-to-Drug Interaction When Administered With CYP3A4 Inhibitors =
OTE0002 / 02.09.2009 / 08:37:05 / Channel: Wirtschaft / Aussender: Kowa
Pitavastatin is Non-Inferior to Atorvastatin and Simvastatin and Demonstrates Sustained Efficacy and Tolerability Over 52 Weeks =
OTE0004 / 01.09.2009 / 14:14:08 / Channel: Wirtschaft / Aussender: Kowa
- 1
